Zhongzhen Guan
- Hepatology top 5%
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 8
-
- Cancer, Hypoxia, and Metabolism 2
-
- Lymphoma Diagnosis and Treatment 6
-
- Lung Cancer Treatments and Mutations 9
-
- Neuroblastoma Research and Treatments 2
-
- Multiple and Secondary Primary Cancers 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Zhongzhen Guan
26 papers receiving 590 citations
Peers
Comparison fields: 5 of 74
- Hepatology 191
- Oncology 233
- Cancer Research 93
- Biomaterials 65
- Pathology and Forensic Medicine 89
Countries citing papers authored by Zhongzhen Guan
This map shows the geographic impact of Zhongzhen Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongzhen Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongzhen Guan more than expected).
Fields of papers citing papers by Zhongzhen Guan
This network shows the impact of papers produced by Zhongzhen Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongzhen Guan. The network helps show where Zhongzhen Guan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongzhen Guan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2018 | 6 | |
| 3 | 2015 | 1 | |
| 4 | 2014 | 23 | |
| 5 | 2014 | 36 | |
| 6 | 2013 | 4 | |
| 7 | 2013 | 115 | |
| 8 | 2012 | 5 | |
| 9 | 2012 | 222 | |
| 10 | 2011 | 30 | |
| 11 | 2010 | 6 | |
| 12 | 2010 | 5 | |
| 13 | 2009 | 17 | |
| 14 | 2008 | 96 | |
| 15 | [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. | 2007 | 2 |
| 16 | [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases]. | 2004 | 1 |
| 17 | [Relationship between expression of survivin and prognosis in human laryngeal squamous cell carcinoma]. | 2004 | 2 |
| 18 | [Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer]. | 2002 | 4 |
| 19 | [Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer]. | 2002 | 3 |
| 20 | Treatment of advanced malignancies with ifosfamide under protection with mesna. | 1988 | 1 |
About Zhongzhen Guan
Zhongzhen Guan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 26 papers that have together received 600 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (8 papers), Lymphoma Diagnosis and Treatment (6 papers), Cancer, Hypoxia, and Metabolism (2 papers), Neuroblastoma Research and Treatments (2 papers), Multiple and Secondary Primary Cancers (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Hepatology (191 citations), Oncology (233 citations) and Cancer Research (93 citations). Zhongzhen Guan has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Wenqi Jiang, Su Li, Anxun Wang, Shiying Yu, Jianming Xu, Giuseppe Lentini, Won Young Tak, Hongming Pan, Shukui Qin and Jun Suk Kim. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.